Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Shelton

Showing results (11-20 of 683) with videos related to

Pageof 69
Sort By:
The Journal of Clinical Psychiatry|May 11, 2006
The nature of the discontinuation syndrome associated with antidepressant drugsRichard C Shelton
Obesity (Silver Spring, Md.)|November 3, 2016
Depression, Antidepressants, and Weight Gain in ChildrenRichard C Shelton
The Lancet. Psychiatry|March 14, 2016
Are placebo-controlled trials of depression safe?Richard C Shelton
Handbook of Experimental Pharmacology|March 7, 2019
Serotonin and Norepinephrine Reuptake InhibitorsRichard C Shelton
The Journal of Clinical Psychiatry|December 17, 2004
The dual-action hypothesis: does pharmacology matter?Richard C Shelton
Primary Care Companion to the Journal of Clinical Psychiatry|March 12, 2004
Steps Following Attainment of Remission: Discontinuation of Antidepressant TherapyRichard C. Shelton
The Journal of Clinical Psychiatry|March 23, 1999
Treatment options for refractory depressionR C Shelton
The Psychiatric Clinics of North America|January 9, 2001
Cellular mechanisms in the vulnerability to depression and response to antidepressantsR C Shelton
Journal of the Royal Society of Medicine|February 2, 2010
The Emperor's new clothesDon C Shelton
CNS Spectrums|January 27, 2009
The role of L-methylfolate in depressive disorders: commentaryRichard C Shelton
Pageof 69

Showing results (11-20 of 683) with videos related to

Sort By:
Pageof 69
The Journal of Clinical Psychiatry|May 11, 2006
The nature of the discontinuation syndrome associated with antidepressant drugsRichard C Shelton
Obesity (Silver Spring, Md.)|November 3, 2016
Depression, Antidepressants, and Weight Gain in ChildrenRichard C Shelton
The Lancet. Psychiatry|March 14, 2016
Are placebo-controlled trials of depression safe?Richard C Shelton
Handbook of Experimental Pharmacology|March 7, 2019
Serotonin and Norepinephrine Reuptake InhibitorsRichard C Shelton
The Journal of Clinical Psychiatry|December 17, 2004
The dual-action hypothesis: does pharmacology matter?Richard C Shelton
Primary Care Companion to the Journal of Clinical Psychiatry|March 12, 2004
Steps Following Attainment of Remission: Discontinuation of Antidepressant TherapyRichard C. Shelton
The Journal of Clinical Psychiatry|March 23, 1999
Treatment options for refractory depressionR C Shelton
The Psychiatric Clinics of North America|January 9, 2001
Cellular mechanisms in the vulnerability to depression and response to antidepressantsR C Shelton
Journal of the Royal Society of Medicine|February 2, 2010
The Emperor's new clothesDon C Shelton
CNS Spectrums|January 27, 2009
The role of L-methylfolate in depressive disorders: commentaryRichard C Shelton
Pageof 69